Ovation Science Inc. (CSE:OVAT)

Market Cap	1.41M
Revenue (ttm)	111.95K
Net Income (ttm)	-641.09K
Shares Out	35.24M
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	35,000
Average Volume	3,983
Open	0.0400
Previous Close	0.0350
Day's Range	0.0400 - 0.0400
52-Week Range	0.0100 - 0.0800
Beta	0.73
RSI	71.72
Earnings Date	May 1, 2025

About Ovation Science

Ovation Science Inc. engages in the production, sub-licensing, and sale of cannabis or hemp products in Canada and the United States. The company sublicenses product formulations through Invisicare, a patented drug delivery technology to produce topical and transdermal cannabis products under the Ovation name. It also offers cannabidiol health and wellness solutions under the Invibe MD name; skincare solutions under the ARLO CBD name; and topical and transdermal creams and lotions with CBD, THC, and combinations, as well as hemp seed oil. Ovati...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2017
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: OVAT

Financial Performance

In 2023, Ovation Science's revenue was 61,934, a decrease of -55.17% compared to the previous year's 138,154. Losses were -813,149, 2.41% more than in 2022.